- Home
- RDHL vs AMBO Comparison
RDHL vs AMBO Comparison
Compare RDHL & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDHL
- AMBO
- Stock Information
- Founded
- RDHL 2009
- AMBO 2000
- Country
- RDHL Israel
- AMBO United States
- Employees
- RDHL N/A
- AMBO 163
- Industry
- RDHL Biotechnology: Pharmaceutical Preparations
- AMBO Other Consumer Services
- Sector
- RDHL Health Care
- AMBO Real Estate
- Exchange
- RDHL Nasdaq
- AMBO Nasdaq
- Market Cap
- RDHL 4.3M
- AMBO 7.0M
- IPO Year
- RDHL N/A
- AMBO 2010
- Fundamental
- Price
- RDHL $2.15
- AMBO $2.95
- Analyst Decision
- RDHL
- AMBO
- Analyst Count
- RDHL 0
- AMBO 0
- Target Price
- RDHL N/A
- AMBO N/A
- AVG Volume (30 Days)
- RDHL 18.4K
- AMBO 10.7K
- Earning Date
- RDHL 08-28-2025
- AMBO 01-01-0001
- Dividend Yield
- RDHL N/A
- AMBO N/A
- EPS Growth
- RDHL N/A
- AMBO N/A
- EPS
- RDHL N/A
- AMBO 0.11
- Revenue
- RDHL $8,042,999.00
- AMBO $9,392,000.00
- Revenue This Year
- RDHL $381.91
- AMBO N/A
- Revenue Next Year
- RDHL N/A
- AMBO N/A
- P/E Ratio
- RDHL N/A
- AMBO $27.78
- Revenue Growth
- RDHL 23.17
- AMBO 2.50
- 52 Week Low
- RDHL $1.71
- AMBO $1.00
- 52 Week High
- RDHL $20.28
- AMBO $5.55
- Technical
- Relative Strength Index (RSI)
- RDHL 64.10
- AMBO 60.08
- Support Level
- RDHL $2.00
- AMBO $2.25
- Resistance Level
- RDHL $2.08
- AMBO $2.70
- Average True Range (ATR)
- RDHL 0.09
- AMBO 0.29
- MACD
- RDHL 0.03
- AMBO 0.08
- Stochastic Oscillator
- RDHL 100.00
- AMBO 72.97
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
About AMBO Ambow Education Holding Ltd.
Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.